Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR) - Total Liabilities

Latest as of March 2026: TL648.60 Million TRY ≈ $14.53 Million USD

Based on the latest financial reports, Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR) has total liabilities worth TL648.60 Million TRY (≈ $14.53 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Meditera Tibbi Malzeme Sanayi ve Ticaret AS - Total Liabilities Trend (2018–2025)

This chart illustrates how Meditera Tibbi Malzeme Sanayi ve Ticaret AS's total liabilities have evolved over time, based on quarterly financial data. See Meditera Tibbi Malzeme Sanayi ve Ticaret (MEDTR) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Meditera Tibbi Malzeme Sanayi ve Ticaret AS Competitors by Total Liabilities

The table below lists competitors of Meditera Tibbi Malzeme Sanayi ve Ticaret AS ranked by their total liabilities.

Company Country Total Liabilities
Sangsangin Investment & Securities Co Ltd
KO:001290
Korea ₩1.05 Trillion
Oriola-KD Oyj A
HE:OKDAV
Finland €830.90 Million
Llorente & Cuenca S.A.
MC:LLYC
Spain €47.82 Million
Mobilicom Limited American Depositary Shares
NASDAQ:MOB
USA $4.41 Million
Hannan Metals Ltd
V:HAN
Canada CA$200.47K
Burning Rock Biotech Ltd
NASDAQ:BNR
USA $285.29 Million
Ta Yih Industrial Co Ltd
TW:1521
Taiwan NT$1.11 Billion
Oriental Food Industries Hold
KLSE:7107
Malaysia RM78.50 Million

Liability Composition Analysis (2018–2025)

This chart breaks down Meditera Tibbi Malzeme Sanayi ve Ticaret AS's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Meditera Tibbi Malzeme Sanayi ve Ticaret.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.58 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.21 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.17 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Meditera Tibbi Malzeme Sanayi ve Ticaret AS's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Meditera Tibbi Malzeme Sanayi ve Ticaret AS (2018–2025)

The table below shows the annual total liabilities of Meditera Tibbi Malzeme Sanayi ve Ticaret AS from 2018 to 2025.

Year Total Liabilities Change
2025-12-31 TL661.10 Million
≈ $14.81 Million
-12.18%
2024-12-31 TL752.75 Million
≈ $16.86 Million
+26.19%
2023-12-31 TL596.54 Million
≈ $13.36 Million
+180.84%
2022-12-31 TL212.41 Million
≈ $4.76 Million
+41.76%
2021-12-31 TL149.84 Million
≈ $3.36 Million
+20.32%
2020-12-31 TL124.53 Million
≈ $2.79 Million
+32.87%
2019-12-31 TL93.72 Million
≈ $2.10 Million
-1.71%
2018-12-31 TL95.36 Million
≈ $2.14 Million
--

About Meditera Tibbi Malzeme Sanayi ve Ticaret AS

IS:MEDTR Turkey Medical Devices
Market Cap
$63.91 Million
TL2.85 Billion TRY
Market Cap Rank
#20990 Global
#343 in Turkey
Share Price
TL30.08
Change (1 day)
+0.07%
52-Week Range
TL26.74 - TL37.54
All Time High
TL52.90
About

Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi manufactures and sells medical devices in Turkey. The company offers two-way and single-line Infusion Systems; Chemotherapy Preparation and Administration Systems, such as medoconco automated drug preparation, diana semi-automatic drug dispensing, and ICU medical chemotherapy drug delivery systems; and respiratory systems products, includin… Read more